Dhanuka Agritech Limited shareholders approved key governance and compensation measures at the company’s 41st Annual General Meeting (AGM) held on August 3, 2026. The most significant outcomes were the approval of the Dhanuka Employee Stock Option Plan 2026 and the Dhanuka Stock Appreciation Rights Plan 2026, both passed as special resolutions. These approvals enable the company to grant equity-linked incentives to eligible employees, aligning long-term employee interests with shareholder value creation.

The AGM, conducted through Video Conferencing (VC) or Other Audio Video Mode (OAVM) in compliance with Ministry of Corporate Affairs (MCA) and Securities and Exchange Board of India (SEBI) circulars, commenced at 11:00 A.M. and concluded at 11:40 A.M. A total of 95 members attended the meeting. The requisite quorum under Section 103 of the Companies Act, 2013, was present throughout the proceedings. Mahendra Kumar Dhanuka, Chairman, chaired the meeting, while Rahul Dhanuka, Managing Director, welcomed the attendees.

In addition to the new incentive plans, shareholders passed ordinary resolutions to reappoint Harsh Dhanuka and Ashish Saraf as Executive Directors. Both executives retired by rotation and offered themselves for re-appointment. The Board also sought ratification for the remuneration payable to the company’s Cost Auditors. The Audited Financial Statements for the Financial Year ended March 31, 2026, along with the Reports of the Board of Directors and Auditors, were received, considered, and adopted.

Key Resolutions Passed

The following resolutions were put to vote via the electronic voting system provided by National Securities Depositories Limited (NSDL), with M/s. VAPN & Associates appointed as the Scrutinizer:

Governance and Compliance

The meeting adhered to regulatory requirements under Section 108 of the Companies Act, 2013, Rule 20 of the Companies (Management and Administration) Rules, 2014, and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Members were provided the facility to exercise their voting rights electronically. The Company Secretary confirmed that the e-voting option remained open for 15 minutes after the conclusion of the AGM for members who had not yet voted.

Mahendra Kumar Dhanuka addressed the shareholders, outlining the company’s operational initiatives, product launches, and growth strategies for FY26. He also highlighted efforts to enhance shareholder wealth through dividends and buy-back programs during the year. The Chairman provided a summary of the financial statements, including the Statutory Auditor’s Report from M/s. S.S. Kothari Mehta & Company LLP and the Secretarial Auditor’s Report from M/s. Ranjeet Pandey & Associates.

Rahul Dhanuka engaged with shareholders, responding to questions regarding the company’s performance and future outlook. The presence of Independent Directors Satish Kumar Gupta, Sanjay Saxena, Sanjiv Goel, Namrata Gupta, and Bajrang Lal Bajaj ensured robust oversight during the proceedings. The results of the e-voting were declared within the stipulated timeframe, and the proceedings were subsequently uploaded to the company’s website and submitted to the National Stock Exchange of India Limited and the BSE Ltd.

Dhanuka Agritech Limited has disclosed the audio recording of its analysts and investors call, held on August 3, 2026, to discuss the unaudited financial results for the quarter ended June 30, 2026 (Q1FY27). The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosures Requirement) Regulations, 2015. The results discussed during the call were approved by the Board of Directors at its meeting held on the same day.

The company reported a net profit of ₹363.04 crore for Q1FY27, a 34.6% decline from ₹555.03 crore in the corresponding prior period. Revenue from operations fell 12.6% to ₹4,619.28 million, primarily due to delayed monsoon onset in key agricultural regions which postponed sowing activities. Despite the revenue contraction, earnings per share (EPS) settled at ₹8.06, compared to ₹12.31 in Q1FY26. The Board also approved a final dividend of 100%, amounting to ₹2 per equity share.

Financial Performance Overview

Total income decreased to ₹4,707.91 million from ₹5,363.32 million in Q1FY26. EBITDA stood at ₹550.10 million, down 33.9% from ₹831.90 million, with EBITDA margins contracting to 11.91% from 15.75%. Gross margins slipped to 35.16% from 36.03%, reflecting price competition and weaker domestic demand. Other income remained relatively stable at ₹88.63 million.

Expenses totaled ₹4,222.17 million, down 8.6% year-on-year. Cost of materials consumed decreased to ₹2,871.33 million from ₹3,614.59 million. Tax expenses were recorded at ₹1,221.92 million, compared to ₹1,904.22 million in Q1FY26. Statutory auditors S S Kothari Mehta & Co. LLP reviewed the unaudited financial results.

Strategic Initiatives and Shareholder Returns

The company is proceeding with a new pesticide manufacturing facility in Nagpur, Maharashtra, with an estimated outlay of up to ₹200 crore. The plant will have an annual capacity of 23,000 MT and is expected to be operational by April 2028. Financing will be sourced through internal accruals and/or debt. Additionally, the Board approved an Employee Stock Option Plan (ESOP) and granted approval for a loan of up to ₹15 crore to the Dhanuka Employee Stock Benefits Trust for implementing the "Dhanuka Stock Appreciation Rights Plan, 2026" under SEBI regulations.

What the Numbers Show

A notable divergence exists between revenue growth and expense management. While revenue contracted by 12.6%, total expenses fell by only 8.6%, leading to a sharper decline in profit before tax (34.8%). This suggests that fixed costs or certain operational expenses did not scale down proportionally with the drop in sales volume. Furthermore, the decline in gross margin to 35.16% indicates pressure on pricing power amidst competitive dynamics. The company’s guidance for FY27 suggests lower single-digit revenue growth and an approximate 200 basis point decline in EBITDA, signaling continued headwinds in the near term.